These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17907236

  • 1. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients.
    Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, Salisbury S, Bean JA.
    Arthritis Rheum; 2007 Oct 15; 57(7):1183-91. PubMed ID: 17907236
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials.
    Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith A, Harding B, Hoogendijk J, Lundberg IE, Marie S, Minetti C, Nennesmo I, Rushing EJ, Sewry C, Charman SC, Pilkington CA, Holton JL, UK Juvenile Dermatomyositis Research Group.
    Arthritis Rheum; 2007 Oct 15; 57(7):1192-201. PubMed ID: 17907237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features.
    Stringer E, Singh-Grewal D, Feldman BM.
    Arthritis Rheum; 2008 Nov 15; 58(11):3585-92. PubMed ID: 18975314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients.
    Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ.
    Arthritis Rheum; 2007 Sep 15; 56(9):3107-11. PubMed ID: 17763414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
    Constantin T, Ponyi A, Orbán I, Molnár K, Dérfalvi B, Dicso F, Kálovics T, Müller J, Garami M, Sallai A, Balogh Z, Szalai Z, Fekete G, Dankó K.
    Autoimmunity; 2006 May 15; 39(3):223-32. PubMed ID: 16769656
    [Abstract] [Full Text] [Related]

  • 10. Cutaneous lesions of dermatomyositis with supervening fibrosis.
    Magro CM, Dyrsen M, Kerns MJ.
    J Cutan Pathol; 2008 Jan 15; 35(1):31-9. PubMed ID: 18095992
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy.
    Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, Rider LG.
    Arthritis Rheum; 2000 Aug 15; 43(8):1866-73. PubMed ID: 10943878
    [Abstract] [Full Text] [Related]

  • 12. Juvenile dermatomyositis: a retrospective review of a 30-year experience.
    Peloro TM, Miller OF, Hahn TF, Newman ED.
    J Am Acad Dermatol; 2001 Jul 15; 45(1):28-34. PubMed ID: 11423831
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.
    Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C, Bodemer C, Brochard-Payet K, Quartier P, Musset L, Chazaud B, Desguerre I, Bader-Meunier B.
    Rheumatology (Oxford); 2016 Mar 15; 55(3):470-9. PubMed ID: 26424834
    [Abstract] [Full Text] [Related]

  • 16. Study of subcutaneous fat in children with juvenile dermatomyositis.
    Verma S, Singh S, Bhalla AK, Khullar M.
    Arthritis Rheum; 2006 Aug 15; 55(4):564-8. PubMed ID: 16874777
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Epidemioclinical aspects of dermatomyositis in the region of Tunis].
    Khelifa E, Benmously R, Fenniche S, Marrak H, Zghal M, Mokhtar I.
    Tunis Med; 2007 Aug 15; 85(8):655-8. PubMed ID: 18254286
    [Abstract] [Full Text] [Related]

  • 19. Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.
    Apaz MT, Saad-Magalhães C, Pistorio A, Ravelli A, de Oliveira Sato J, Marcantoni MB, Meiorin S, Filocamo G, Pilkington C, Maillard S, Al-Mayouf S, Prahalad S, Fasth A, Joos R, Schikler K, Mozolova D, Landgraf JM, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation.
    Arthritis Rheum; 2009 Apr 15; 61(4):509-17. PubMed ID: 19333974
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients.
    Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, Maillard S, Oliveira SK, Sztajnbok F, Cuttica R, Beltramelli M, Corona F, Katsicas MM, Russo R, Ferriani V, Burgos-Vargas R, Magni-Manzoni S, Solis-Valleoj E, Bandeira M, Zulian F, Baca V, Cortis E, Falcini F, Alessio M, Alpigiani MG, Gerloni V, Saad-Magalhaes C, Podda R, Silva CA, Lepore L, Felici E, Rossi F, Sala E, Martini A.
    Arthritis Care Res (Hoboken); 2010 Jan 15; 62(1):63-72. PubMed ID: 20191492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.